Search Results 161-170 of 16158 for Thrombocytopenia
Research. Mayo Clinic researchers study what can cause immune thrombocytopenia (ITP) and new ways to treat it. Publications.
The purpose of this study is to evaluate the effectiveness and safety of PANZYGA in pediatric patients with chronic Immune Thrombocytopenia (ITP). Participation ...
... thrombocytopenia (ITP). This medicine is used after a splenectomy (surgery to remove the spleen) or when other medicines (eg, steroids or immunoglobulins) ...
... thrombocytopenia (ITP). This medicine is used after a splenectomy (surgery ... Eltrombopag is also used to treat thrombocytopenia in patients with chronic ...
The study drug will be administered orally in participants with Primary Immune Thrombocytopenia (ITP). Blood tests will be performed to check how much ...
Avatrombopag is used to treat thrombocytopenia (low platelets in the blood) in adults with chronic liver disease who are scheduled to have a medical or dental ...
Towards Precise and Rapid Diagnosis of Heparin-Induced Thrombocytopenia: a Prospective, Multicentre Cohort Study (“TORADI-HIT”) · Share · Facebook · Twitter.
... thrombocytopenia and myelofibrosis achieving ≥ 35% reduction in spleen volume from baseline to Week 24 than treatment with Best Available Therapy, and a ...
Phase 3b open-label, multicenter study to evaluate the safety and efficacy of avatrombopag in subjects with thrombocytopenia scheduled for operations to ...
Low platelet count, called thrombocytopenia, isn't a concern for most surgeries unless the level is less than 50,000 per µL. A platelet level of 111,000 per ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.